Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder
Adopted by FSMB House of Delegates, April 2024
Showing 41-50 of 239 results
Adopted by FSMB House of Delegates, April 2024
Report of the FSMB Ethics and Professionalism Committee
Washington, D.C. (March 28, 2017) –The Federation of State Medical Boards (FSMB) has released the latest episode of its “FSMB Spotlight” series which features interviews with health care
This report addresses physician behaviors and practices within the scope of unprofessional conduct that can negatively impact patient safety and welfare and/or the physician-patient
This report outlines emerging model practices for state medical and osteopathic boards for achieving greater cooperation and collaboration with other health professional boards in fulfilling
WASHINGTON, D.C. (July 13, 2020) – The Federation of State Medical Boards (FSMB) has ... announced its com/fsmb" target="_blank">FSMB 2020 Virtual Education
the distribution of counterfeit or contaminated drugs. Appearing in Volume 104, #1, the articles include: ... Prescription Drugs from Rogue Wholesale Distributors A commentary from the U.S. Food and Drug Administration
WASHINGTON, D.C. (June 17, 2016) – The U.S. Health Resources and Services Administration ... an agency of the U.S. Department of Health and Human Services, has announced that it will provide funding